Fritextsökning
Innehållstyper
-
Fler lungor till transplantationsstudie
Xvivo knyter till sig den tionde kliniken i bolagets USA-studie där bolagets transplantationsteknik utvärderas.
-
Uppåt för Xvivo
Ökade försäljningen med 74 procent men resultatet dras ner av rättegångskostnader.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Roche i uppköpsrykte
Förändringar i ägarstrukturen har satt igång spekulationer om att Novartis kommer att köpa upp Roche.
-
Vivoline och Xvivo når uppgörelse
Xvivo ska betala 1,6 miljoner till Vivoline efter en uppgörelse utanför tingsrätten.
-
Karo Bio bygger miljonlabb
Forskningsbolaget har beställt nya renrum i lokalerna i Huddinge utanför Stockholm.
-
Ny plattform för akademisk läkemedelsutveckling
I regeringens forskningsproposition satsas 50 miljoner på en plattform för läkemedelsutveckling. Projektet som leds av Scilifelab hämtar inspiration från det am...
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Ny vd på Monocl
Ann Gidner tar tyglarna på konsultbolaget.
-
FDA godkänner Zubsolv
Orexos läkemedel Zubsolv används som underhållsbehandling av opiatberoende, godkänns för den amerikanska marknaden.
-
Take off for this year's fair
More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Stille säljer verksamhetsdel
Renodlar bolagets affärsmodell för att fokusera mer på specialiserad kirurgi.
-
Showroom for free
The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Orexos dotterbolag får ny vd
Igår meddelade Orexo att Robert A DeLuca blir ny vd för det amerikanska dotterbolaget inför lanseringen av Zubsolv i USA.
-
Ny tillförordnad vd till Boule Diagnostics dotterbolag
Koncernledningen skickar cfo:n Fredrik Alpsten till USA för att stärka samarbetet mellan verksamheterna.
BREAKING